204 related articles for article (PubMed ID: 23289001)
1. Three-year review of bacteriological profile and antibiogram of burn wound isolates in Van, Turkey.
Bayram Y; Parlak M; Aypak C; Bayram I
Int J Med Sci; 2013; 10(1):19-23. PubMed ID: 23289001
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
3. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
4. Bacteriologic Profile of Burn Wounds at a Tertiary Government Hospital in the Philippines-UP-PGH ATR Burn Center.
Abesamis GMM; Cruz JJV
J Burn Care Res; 2019 Aug; 40(5):658-668. PubMed ID: 30941412
[TBL] [Abstract][Full Text] [Related]
5. The Bacteriological Profile of Burn Wound Infections at a Tertiary Burns Center in Nepal.
Pujji OJS; Nakarmi KK; Shrestha B; Rai SM; Jeffery SLA
J Burn Care Res; 2019 Oct; 40(6):838-845. PubMed ID: 31197366
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of multidrug-resistant organisms recovered at a military burn center.
Keen EF; Robinson BJ; Hospenthal DR; Aldous WK; Wolf SE; Chung KK; Murray CK
Burns; 2010 Sep; 36(6):819-25. PubMed ID: 20080354
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of distribution and drug resistance of pathogens of burn patients during 9 years].
Dou Y; Zhang Q
Zhonghua Shao Shang Za Zhi; 2018 Mar; 34(3):153-159. PubMed ID: 29609277
[No Abstract] [Full Text] [Related]
8. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
[TBL] [Abstract][Full Text] [Related]
9. The antimicrobial efficacy of silver on antibiotic-resistant bacteria isolated from burn wounds.
Percival SL; Thomas J; Linton S; Okel T; Corum L; Slone W
Int Wound J; 2012 Oct; 9(5):488-93. PubMed ID: 22182219
[TBL] [Abstract][Full Text] [Related]
10. Common pathogens in burn wound and changes in their drug sensitivity.
Rezaei E; Safari H; Naderinasab M; Aliakbarian H
Burns; 2011 Aug; 37(5):805-7. PubMed ID: 21388742
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
Zhang Z; Chen M; Yu Y; Pan S; Liu Y
Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308
[TBL] [Abstract][Full Text] [Related]
12. Bacteriology of burns.
Revathi G; Puri J; Jain BK
Burns; 1998 Jun; 24(4):347-9. PubMed ID: 9688200
[TBL] [Abstract][Full Text] [Related]
13. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
[TBL] [Abstract][Full Text] [Related]
14. [[The profile of antibiotic resistantpathogens isolated from ascites fluid patients in intensive care unit during past 12 years].
Kong Q; Hu L; Zhou Z; Shen J; Xu X; Ye Y; Zhang Z; Li J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):211-6. PubMed ID: 29916671
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients.
Timurkaynak F; Arslan H; Azap OK; Senger SS; Başaran O; Karaman SO; Haberal M
Burns; 2008 Nov; 34(7):1033-6. PubMed ID: 18539397
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2011-2016.
Dowzicky MJ; Chmelařová E
J Glob Antimicrob Resist; 2019 Jun; 17():44-52. PubMed ID: 30445209
[TBL] [Abstract][Full Text] [Related]
17. Changes in bacterial isolates from burn wounds and their antibiograms: a 20-year study (1986-2005).
Guggenheim M; Zbinden R; Handschin AE; Gohritz A; Altintas MA; Giovanoli P
Burns; 2009 Jun; 35(4):553-60. PubMed ID: 19167827
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
19. Burn-associated bloodstream infections in pediatric burn patients: Time distribution of etiologic agents.
Devrim İ; Kara A; Düzgöl M; Karkıner A; Bayram N; Temir G; Şencan A; Sorguç Y; Gülfidan G; Hoşgör M
Burns; 2017 Feb; 43(1):144-148. PubMed ID: 27615546
[TBL] [Abstract][Full Text] [Related]
20. Emerging infections in burns.
Branski LK; Al-Mousawi A; Rivero H; Jeschke MG; Sanford AP; Herndon DN
Surg Infect (Larchmt); 2009 Oct; 10(5):389-97. PubMed ID: 19810827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
